The Delaware R&D Tax Credit: A Comprehensive Guide to Qualified Research Expenses (QREs), Statutory Compliance, and Maximizing Refundability
Qualified Research Expenses (QREs) are defined as costs, including employee wages, supplies, and contract research, paid or incurred during activities aimed at discovering technological information to improve a product or process. In the context of the Delaware R&D Tax Credit, these expenses must not only satisfy stringent federal criteria but also be strictly limited to activities physically conducted within the State of Delaware.
The Delaware Research and Development (R&D) Tax Credit, codified under Del. Code Ann. tit. 30, §§ 2070-2075, is a primary driver for incentivizing innovation within the state.1 Administered by the Delaware Division of Revenue (DOR), this incentive is highly valued because it is structured as a fully refundable credit, meaning taxpayers receive a cash payment for any portion of the credit that exceeds their state tax liability.1 This mechanism is particularly beneficial for startups and growth-stage companies across industries like biotechnology, advanced manufacturing, and software development, which often incur significant R&D costs before generating taxable income.1 Crucially, Delaware’s definition of QREs aligns with the federal standards set forth in Internal Revenue Code (IRC) Section 41, but with a critical additional requirement: strict geographic apportionment to activities performed exclusively within the state.1 Understanding this federal foundation and the local calculation methods is essential for maximizing the credit’s strategic value.
II. Defining the Foundation: Federal Qualified Research Expenses (QREs)
Delaware’s R&D credit statute relies entirely on the federal framework established under IRC § 41 to determine whether an expense qualifies as a QRE.4 Before any expense can be considered for the Delaware credit, it must first be eligible under federal law and incurred by the taxpayer in carrying on a trade or business.5
A. The Requirement for Qualified Research Activities (QRAs)
QREs are costs associated with research activities that satisfy the rigorous Four-Part Test defined in IRC § 41(d).6 These activities must be aimed at discovering technological information necessary for the development or improvement of a business component, such as a product, process, technique, formula, or invention.7
1. The Four-Part Test Criteria
The four elements that must be met by the activity related to the business component are 6:
- Permitted Purpose: The objective of the research must be to create or improve a product or process in terms of function, performance, reliability, or quality.
- Elimination of Technical Uncertainty: The activity must seek to discover information that resolves technical uncertainties existing at the project’s onset regarding the product’s capability, the development method, or the appropriate design.
- Technological in Nature: The discovery process must rely fundamentally on the principles of a hard science, such as computer science, engineering, physics, or chemistry.
- Process of Experimentation: There must be evidence of a systematic process, such as modeling, simulation, or rigorous testing, designed to evaluate alternatives and eliminate the technical uncertainties identified.
The adherence to the technological and experimental criteria of the Four-Part Test imposes a significant data collection and documentation requirement.1 If a company fails to maintain records proving that a systematic process of experimentation was used to resolve a specific technical uncertainty, the related expenses will not qualify under federal law, rendering them immediately ineligible for the Delaware credit. This necessity for detailed, project-level documentation is often a primary area of focus during a Delaware Division of Revenue audit.1
B. Eligible Categories of QREs (IRC § 41)
QREs fall into three distinct categories, provided they are tied directly to qualified research activities:
1. Wages for Qualified Services
This category includes wages paid or incurred to employees for services consisting of engaging in qualified research, or directly supervising or supporting qualified research.8 Wages are defined consistently with IRC § 3401(a).8 If an employee performs substantially all (80% or more) of their services for the taxpayer during the year in qualified activities, then 100% of their wages may be counted as qualified services.9
For Delaware, a key constraint applies: only wages paid for services physically performed within the state can be included in the calculation of Delaware QREs.1 This geographic nexus means that businesses with employees working remotely or splitting time between Delaware and neighboring states must employ rigorous payroll tracking and time allocation methodologies to ensure accurate apportionment.
2. Qualified Supplies
Supplies are defined as tangible property used or consumed in the execution of qualified research.7 Eligible supply costs include, but are not limited to, laboratory chemicals, computer components for software development, and raw materials used to fabricate and test prototypes.7
However, the definition strictly excludes land, improvements to land, and any tangible property that is capitalized or subject to depreciation.7 Additionally, general business expenses, such as general office materials, utilities, administrative costs, or overhead charges, are ineligible QREs.7
3. Contract Research Expenses (CREs)
These expenses cover amounts paid or incurred to third parties (independent contractors or consultants) for conducting qualified research on the taxpayer’s behalf.7 Under federal law, only 65% of the contract research costs are eligible to be treated as QREs. Furthermore, the taxpayer must maintain substantial rights to the research performed by the contractor and bear the economic risk associated with the development.7
For the Delaware credit, the geographic restriction remains paramount: the research services performed by the contractor must be physically conducted within the State of Delaware to count as Delaware-apportioned QREs.
III. The Delaware R&D Credit Framework (Del. Code Ann. tit. 30, §§ 2070-2075)
Delaware’s statute governs the credit computation, applying state-specific rates and methodologies to the federally compliant QRE base.
A. Adopting and Apportioning QREs (The Delaware Nexus)
The foundational difference between the federal R&D credit and the Delaware R&D credit lies in the scope of eligible expenditures. The Delaware credit only recognizes Delaware-apportioned QREs.1 This means that the expense, whether it is a wage, a supply consumption, or a contract service, must be directly related to qualified research activities that physically took place within the borders of Delaware.
This strict geographic requirement significantly impacts companies that operate across state lines. The Delaware Division of Revenue mandates that the taxpayer maintain records that clearly delineate which portion of total QREs is attributable to in-state research.1 This rigorous apportionment process is specifically highlighted in DOR audit activity, where compliance officers verify both the federal eligibility of the activity and the accuracy of its geographic assignment to Delaware.1
B. Core Features: Refundability and Strategic Flexibility
Delaware has deliberately structured its credit to be highly attractive to innovative businesses, particularly by offering cash liquidity and enhanced rates for smaller entities.
1. Full Refundability
One of the most valuable aspects of the Delaware R&D Tax Credit is its fully refundable nature.1 Since 2017, the statewide expenditure cap was eliminated, reinforcing the state’s commitment to this incentive.2 This means that a taxpayer is not required to have a current state tax liability to benefit; any approved credit amount that exceeds the tax due is paid directly to the company as a cash refund.1 This feature provides non-dilutive capital to high-growth, pre-profit companies, which often have high R&D expenditures but minimal current income tax obligations.
2. Small Business Enhancement
Delaware offers accelerated credit rates for taxpayers that meet the definition of a “small business.” A small business is defined as any taxpayer with average annual gross receipts, as determined by IRC § 41(c)(1)(B), that do not exceed the threshold of $20,000,000.4 This enhanced incentive structure encourages smaller, emerging R&D firms to establish and expand their operations within the state.
3. Independent Annual Election
Taxpayers claiming the Delaware R&D credit must choose one of two available calculation methods, Method A or Method B, on an annual basis.12 Crucially, the Delaware research and development tax credit determination election is independent of the method used to compute the federal R&D tax credit.4 This decoupling allows sophisticated tax planning strategies where a company might use one methodology federally (e.g., the Regular Credit) but elect the most favorable method for the Delaware calculation based on historical data and current-year expenditures.
IV. Detailed Calculation Methods and Rate Structures
The annual election requires taxpayers to compare the outcomes of two distinct methodologies for calculating the final credit amount (Del. Code Ann. tit. 30, § 2070(a)).4
A. Method A: The Incremental Approach (Excess QREs over Base Amount)
Method A calculates the credit as a percentage of the taxpayer’s “excess” Delaware QREs over their Delaware Base Amount (DBA).1 This method requires the taxpayer to calculate historical expenditures and receipts from the four preceding taxable years.12
1. Calculation of the Delaware Base Amount (DBA)
The calculation of the DBA involves three steps, based on the process outlined in Form 2071AC 1:
- Step 1: Determine the Delaware Fixed Base Percentage (FBP). This is calculated by dividing the total Delaware QREs for the four preceding years by the total Delaware gross receipts for the same period 12:
$$\text{FBP} = \frac{\text{Total Delaware QREs for the 4 years preceding the credit year}}{\text{Total Delaware gross receipts for the 4 years preceding the credit year}}$$ - Step 2: Calculate the Base Amount. The base amount is calculated by multiplying the FBP by the average annual Delaware gross receipts for the four preceding years.12
- Step 3: Apply the Minimum Floor. The final Delaware Base Amount (DBA) used for the subtraction is the greater of the calculated result from Step 2 or a minimum threshold equal to 50% of the current-year Delaware QREs.1
The inclusion of the 50% minimum floor is a key regulatory feature that limits the credit primarily to businesses demonstrating incremental growth in their R&D spending.1 A company that maintains high but consistent R&D spending year-over-year may find that the 50% floor significantly reduces or eliminates the “excess” QREs eligible for the credit under Method A.
2. Credit Rates for Method A
The credit rate is applied to the calculated excess QREs (Current Year QREs – DBA).
| Taxpayer Status | Credit Rate Applied to Excess QREs | Reference |
| Standard Taxpayer (Gross Receipts > $20M) | 10% | 4 |
| Small Business (Gross Receipts $\le \$20M$) | 20% | 1 |
B. Method B: Apportioned Federal Alternative Simplified Credit (ASC)
Method B provides an alternative calculation based on the federal Alternative Simplified Credit (ASC), defined under IRC § 41(c)(5).4 This method requires the taxpayer to calculate their federal credit using the ASC, then apportions that federal amount to Delaware.
1. Apportionment Calculation
The federal ASC is apportioned using a ratio comparing Delaware QREs to the taxpayer’s total U.S. QREs for the taxable year 4:
$$\text{Delaware Apportioned ASC} = \text{Federal ASC} \times \frac{\text{Delaware QREs for the taxable year}}{\text{Total Qualified Research Expenses for the taxable year}}$$
11
2. Credit Rates for Method B
The state credit is then calculated as a percentage of this Delaware Apportioned ASC:
| Taxpayer Status | Credit Rate Applied to Apportioned ASC | Reference |
| Standard Taxpayer (Gross Receipts > $20M) | 50% | 4 |
| Small Business (Gross Receipts $\le \$20M$) | 100% | 4 |
The provision allowing small businesses to claim 100% of the Delaware-apportioned Federal ASC is a key competitive advantage, often yielding a higher credit amount compared to Method A, especially for businesses with less robust historical QRE growth or those newly crossing the threshold of needing R&D documentation.4
V. Division of Revenue Compliance and Filing Requirements
The Delaware Division of Revenue (DOR) oversees the administration of the credit. Strict adherence to local administrative procedures and deadlines is mandatory for credit approval.
A. Application Protocol: Form 2071AC and Key Deadlines
To claim the refundable credit, a taxpayer must submit an annual application on Form 2071AC, titled the “Application and Computation Schedule for Claiming Delaware Research and Development Tax Credits”.12
The filing deadline is critical: Form 2071AC must be completed and submitted to the DOR on or before September 15th after the end of the taxable year during which the qualified R&D expenses were made.12
A copy of Federal Form 6765, the federal research credit form, must be attached to the Delaware application, regardless of whether the taxpayer elects Method A or Method B for the state credit.12 If the applicant files a consolidated federal corporate income tax return, a proforma Federal Form 6765 specific to the corporate applicant must be attached instead.12 Once the credit is approved, the final amount is entered on Form 700, the Delaware Income Tax Credit Schedule.12 For pass-through entities, the credit is typically distributed to partners or shareholders via Schedule K-1.1
B. Audit Readiness and Documentation Mandate
The DOR places significant emphasis on robust documentation to validate claims, particularly concerning the geographic allocation of QREs.1 Taxpayers are required to retain records for the applicable statute of limitations period (generally three years for corporate income tax).1
Audits of the Delaware R&D tax credit focus specifically on two critical areas:
- IRC § 41 Compliance: Verification that the claimed activities satisfy the Four-Part Test and that expenses meet the federal definition of wages, supplies, or contract research (e.g., ensuring capital expenditures or administrative costs are excluded).1
- Delaware Apportionment: Verification that the QREs were physically incurred in Delaware. This requires maintaining detailed project records, payroll logs, and contracts that clearly indicate the situs of the qualified research.1
Furthermore, documentation must support the underlying data required for the calculation methods, necessitating records of prior four years’ Delaware QREs and gross receipts, even if Method B is elected in the current year, to provide comprehensive support for the claim history.1
VI. Case Study: Application of QREs and Credit Calculation Modeling
A detailed model demonstrates the strategic choice required when electing between the two calculation methods, especially for a Delaware small business aiming to maximize its refundable cash benefit.
A. Scenario Setup: Delaware Biotech Firm
Consider a biotech firm located in Dover, Delaware, with fewer than 50 employees and average annual gross receipts well below the $20 million threshold, qualifying it as a “Small Business”.4
| Metric | Value | Source |
| Current Year (CY) Delaware QREs | $1,000,000 | 1 |
| Total U.S. QREs (CY) | $1,200,000 | |
| Federal R&D Credit (ASC Method) | $100,000 | |
| Total Prior 4 Years Delaware QREs | $1,500,000 | 12 |
| Total Prior 4 Years Delaware Gross Receipts | $10,000,000 | 12 |
| Average Annual Gross Receipts (4 Yrs) | $2,500,000 | 12 |
B. Calculation: Method A (Incremental Approach, 20% Rate)
Method A uses the enhanced 20% rate for small businesses applied to QREs exceeding the Base Amount.4
| Calculation Step | Formula / Value | Result |
| 1. Fixed Base Percentage (FBP) | $\$1,500,000 / \$10,000,000$ | $15.00\%$ |
| 2. Calculated Base Amount (CBA) | $15.00\% \times \$2,500,000$ | $\$375,000$ |
| 3. Minimum Base Floor (50% of CY QREs) | $50\% \times \$1,000,000$ | $\$500,000$ |
| 4. Delaware Base Amount (DBA) | $\text{Greater of CBA or Floor}$ | $\mathbf{\$500,000}$ |
| 5. Excess QREs | $\$1,000,000 – \$500,000$ | $\$500,000$ |
| 6. Credit Amount (20% Rate) | $\$500,000 \times 20\%$ | $100,000 |
C. Calculation: Method B (Apportioned Federal ASC, 100% Rate)
Method B uses the maximum 100% small business rate applied to the apportioned federal ASC.4
| Calculation Step | Formula / Value | Result |
| 1. Apportionment Ratio | Delaware QREs / Total U.S. QREs: $\$1,000,000 / \$1,200,000$ | $83.33\%$ |
| 2. Delaware Apportioned ASC | Federal ASC $\times$ Ratio: $\$100,000 \times 83.33\%$ | $\$83,333$ |
| 3. Credit Amount (100% Rate) | $\$83,333 \times 100\%$ | $83,333 |
D. Comparative Analysis
Table 4: Comparative R&D Tax Credit Outcomes for Small Business
| Calculation Method | Calculated Credit |
| Method A (Incremental) | $100,000 |
| Method B (Apportioned ASC) | $83,333 |
The results demonstrate that in this scenario, where the company’s current QREs significantly exceed its historical fixed base percentage (15.00%), Method A provides the superior result, maximizing the refundable credit at $100,000. If the historical QRE base were higher, or the current year’s QRE growth less substantial, Method B might have been more advantageous. This variability necessitates a thorough, annual comparison of both options prior to the September 15th filing deadline.
VII. Conclusion and Strategic Recommendations
The Delaware R&D Tax Credit is a highly effective policy mechanism designed to foster local innovation, offering benefits that often surpass those available in other states due to its fully refundable nature.1 The credit structure encourages high R&D intensity, particularly among small businesses that benefit from enhanced rates (up to 20% incremental or 100% of apportioned ASC).4
For businesses seeking to successfully utilize the Delaware R&D credit, the analysis shows that focus must be placed simultaneously on stringent federal criteria and narrow state apportionment rules. To ensure eligibility and maximize the refundable cash benefit, businesses should adhere to the following strategic imperatives:
- Establish Dual Compliance: Taxpayers must ensure the underlying activities and expenses meet the technological and systematic requirements of IRC § 41 (the Four-Part Test) and must maintain comprehensive documentation to prove compliance in the event of an audit.1
- Verify Geographic Nexus: All claimed QREs must be strictly limited to costs incurred for research activities physically performed within Delaware. Multi-state or remote work structures require specialized systems to accurately apportion employee wages and contractor services to the state to prevent claim rejection based on insufficient local nexus.1
- Optimize Annual Election: Due to the independent nature of the Delaware election and the enhanced rates for small businesses, companies must model both the Incremental Approach (Method A) and the Apportioned Federal ASC (Method B) every year to select the calculation that yields the highest credit, thereby maximizing their non-dilutive capital return.4 Timely submission of Form 2071AC by the September 15th deadline is essential to secure the credit.12
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state










